BioCentury | Oct 13, 2020
Finance

Chord launches with $16M to test MS drug cladribine in rare autoimmune disorders

...Wilson CSO Tom Plitz. Omega Funds was the sole investor in the series A round for Chord Therapeutics...
...connection with the financing, Omega Funds’ Claudio Nessi and Francesco Draetta will join Chord’s board. Stephen Hansen CRD1 Chord Therapeutics S.a.r.l....
Items per page:
1 - 1 of 1
BioCentury | Oct 13, 2020
Finance

Chord launches with $16M to test MS drug cladribine in rare autoimmune disorders

...Wilson CSO Tom Plitz. Omega Funds was the sole investor in the series A round for Chord Therapeutics...
...connection with the financing, Omega Funds’ Claudio Nessi and Francesco Draetta will join Chord’s board. Stephen Hansen CRD1 Chord Therapeutics S.a.r.l....
Items per page:
1 - 1 of 1